Western blot analyses showed a dose-dependent accumulation of TFPI protein in the cell lysates after rTFPI treatment for 24 h (Fig. 4A,B), which indicates that exogenous TFPI binds to or enters the CLL cells. This evidence concerns the gene TFPI and B-cell chronic lymphocytic leukemia.